{"id":7536,"date":"2025-04-10T09:06:09","date_gmt":"2025-04-10T09:06:09","guid":{"rendered":"https:\/\/tst.incliva.es\/?page_id=7536"},"modified":"2025-04-10T09:06:09","modified_gmt":"2025-04-10T09:06:09","slug":"m-jose-terol-castera","status":"publish","type":"page","link":"https:\/\/tst.incliva.es\/en\/m-jose-terol-castera\/","title":{"rendered":"M\u00aa Jos\u00e9 Terol Caster\u00e1"},"content":{"rendered":"<p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container fusion-parallax-none nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: #ededed;background-image: url(&quot;https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/01\/fondo.jpg&quot;);background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#e2e2e2;border-style:solid;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\">\n<div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_3_4 3_4 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\">\n<div class=\"fusion-text fusion-text-1\" style=\"transform:translate3d(0,0,0);\"><h3>Dr. M\u00aa Jos\u00e9 Terol Caster\u00e1 <\/h3>\n<\/div>\n<div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-bottom:3px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div>\n<div class=\"fusion-text fusion-text-2\" style=\"transform:translate3d(0,0,0);\"><h5><span style=\"color: #3D44AC;\">Principal Investigator<br \/>\nResearch Group on Lymphoproliferative Disorders<br \/>\n<\/span><\/h5>\n<\/div>\n<div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-bottom:10px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div>\n<div class=\"fusion-text fusion-text-3\" style=\"transform:translate3d(0,0,0);\"><h4 style=\"text-align: justify;\">Presentation<\/h4>\n<\/div>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-0{width:75% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-0 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 2.56%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 2.56%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-column-0{width:75% !important;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 2.56%;margin-left : 2.56%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-0{width:100% !important;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_1_4 1_4 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#ffffff;border-width: 0 0 0 2px;border-color:#9da0d2;border-style:solid;padding: 4% 4% 4% 4%;\">\n<div ><span class=\" fusion-imageframe imageframe-none imageframe-1 hover-type-none\" style=\"border-radius:5px;\"><img src=\"\/wp-content\/uploads\/2022\/10\/Maria-Jose-Terol-Castera_FIH17.jpg\" class=\"img-responsive\"\/><\/span><\/div>\n<div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:10px;margin-bottom:10px;width:100%;\"><\/div>\n<div class=\"fusion-text fusion-text-4\" style=\"transform:translate3d(0,0,0);\"><h5 style=\"text-align: center;\">Principal<br \/>\nInvestigator<\/h5>\n<div style=\"text-align: center;\">Dr. M\u00aa Jos\u00e9 Terol Caster\u00e1 <\/div>\n<p style=\"text-align: center;\"><a href=\"mailto:maria.jose.terol@uv.es \u00a0\">maria.jose.terol@uv.es \u00a0<\/a><\/p>\n<\/div>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-1{width:25% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-1 > .fusion-column-wrapper {padding-top : 4% !important;padding-right : 4% !important;margin-right : 7.68%;padding-bottom : 4% !important;padding-left : 4% !important;margin-left : 7.68%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-column-1{width:25% !important;order : 0;}.fusion-builder-column-1 > .fusion-column-wrapper {margin-right : 7.68%;margin-left : 7.68%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-1{width:100% !important;order : 0;}.fusion-builder-column-1 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<\/div>\n<style type=\"text\/css\">.fusion-fullwidth.fusion-builder-row-1 { overflow:visible; }.fusion-body .fusion-flex-container.fusion-builder-row-1{ padding-top : 2%;margin-top : 0px;padding-right : 0px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 0px;}<\/style><\/div><br \/>\n<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: #e5e5e5;background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#e2e2e2;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\">\n<div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_1_1 1_1 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\">\n<div class=\"fusion-text fusion-text-5\" style=\"transform:translate3d(0,0,0);\"><h5>Publications<\/h5>\n<\/div>\n<div class=\"fusion-tabs fusion-tabs-1 classic horizontal-tabs icon-position-left\"><style type=\"text\/css\">.fusion-tabs.fusion-tabs-1 .nav-tabs li a.tab-link{border-top-color:#f9f9fb;background-color:#f9f9fb;}.fusion-tabs.fusion-tabs-1 .nav-tabs{background-color:#ffffff;}.fusion-tabs.fusion-tabs-1 .nav-tabs li.active a.tab-link,.fusion-tabs.fusion-tabs-1 .nav-tabs li.active a.tab-link:hover,.fusion-tabs.fusion-tabs-1 .nav-tabs li.active a.tab-link:focus{border-right-color:#ffffff;}.fusion-tabs.fusion-tabs-1 .nav-tabs li.active a.tab-link,.fusion-tabs.fusion-tabs-1 .nav-tabs li.active a.tab-link:hover,.fusion-tabs.fusion-tabs-1 .nav-tabs li.active a.tab-link:focus{background-color:#ffffff;}.fusion-tabs.fusion-tabs-1 .nav-tabs li a:hover{background-color:#ffffff;border-top-color:#ffffff;}.fusion-tabs.fusion-tabs-1 .tab-pane{background-color:#ffffff;}.fusion-tabs.fusion-tabs-1 .nav,.fusion-tabs.fusion-tabs-1 .nav-tabs,.fusion-tabs.fusion-tabs-1 .tab-content .tab-pane{border-color:#e2e2e2;}<\/style><div class=\"nav\"><ul class=\"nav-tabs nav-justified\" role=\"tablist\"><li class=\"active\"><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-c5c45463bad8552b89b\" aria-selected=\"true\" id=\"fusion-tab-2024\" href=\"#tab-c5c45463bad8552b89b\"><h4 class=\"fusion-tab-heading\">2024<\/h4><\/a><\/li><li><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-e568011b6133c7d0bcf\" aria-selected=\"false\" tabindex=\"-1\" id=\"fusion-tab-2023\" href=\"#tab-e568011b6133c7d0bcf\"><h4 class=\"fusion-tab-heading\">2023<\/h4><\/a><\/li><li><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-a574f324e5d753180d4\" aria-selected=\"false\" tabindex=\"-1\" id=\"fusion-tab-2022\" href=\"#tab-a574f324e5d753180d4\"><h4 class=\"fusion-tab-heading\">2022<\/h4><\/a><\/li><li><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-dad86f19f0d357d57f7\" aria-selected=\"false\" tabindex=\"-1\" id=\"fusion-tab-2021\" href=\"#tab-dad86f19f0d357d57f7\"><h4 class=\"fusion-tab-heading\">2021<\/h4><\/a><\/li><\/ul><\/div><div class=\"tab-content\"><div class=\"nav fusion-mobile-tab-nav\"><ul class=\"nav-tabs nav-justified\"><li class=\"active\"><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-c5c45463bad8552b89b\" aria-selected=\"true\" id=\"mobile-fusion-tab-2024\" href=\"#tab-c5c45463bad8552b89b\"><h4 class=\"fusion-tab-heading\">2024<\/h4><\/a><\/li><\/ul><\/div><div class=\"tab-pane fade fusion-clearfix in active\" role=\"tabpanel\" tabindex=\"0\" aria-labelledby=\"fusion-tab-2024\" id=\"tab-c5c45463bad8552b89b\">\n<div style=\"padding-top:4%;padding-left:4%; padding-right:4%; text-align:justify;\">\nFeasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial. Ribera J, Morgades M, Garcia-Calduch O, Sirvent M, Buendia B, Cervera M, Luzardo H, Hernandez-Rivas J, Sitges M, Garcia-Cadenas I, Abrisqueta P, Montesinos P, Bastos-Oreiro M, De Llano M, Bravo P, Torrent A, Herrera P, Garcia-Guinon A, Vall-Llovera F, Serrano J, Terol M, Bergua J, Garcia-Noblejas A, Barrenetxea C, Llorente L, Garcia-Belmonte D, Gimeno E, Cladera A, Mercadal S, Sancho J. Haematologica. 2024 Feb 1;109(2):543-552. doi: <a href='https:\/\/doi.org\/10.3324\/haematol.2023.283342' target='_blank'>10.3324\/haematol.2023.283342<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37560813' target='_blank'>37560813<\/a><\/p>\n<\/div>\n<\/div><div class=\"nav fusion-mobile-tab-nav\"><ul class=\"nav-tabs nav-justified\"><li><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-e568011b6133c7d0bcf\" aria-selected=\"false\" tabindex=\"-1\" id=\"mobile-fusion-tab-2023\" href=\"#tab-e568011b6133c7d0bcf\"><h4 class=\"fusion-tab-heading\">2023<\/h4><\/a><\/li><\/ul><\/div><div class=\"tab-pane fade fusion-clearfix\" role=\"tabpanel\" tabindex=\"0\" aria-labelledby=\"fusion-tab-2023\" id=\"tab-e568011b6133c7d0bcf\">\n<div style=\"padding-top:4%;padding-left:4%; padding-right:4%; text-align:justify;\">\nAccuracy and prognostic impact of FDG PET\/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: a nation-wide cohort study. Rodenas-Quinonero I, Chen-Liang T, Martin-Santos T, Salar A, Fernandez-Gonzalez M, Celades C, Navarro J, Martinez-Garcia A, Andreu R, Balaguer A, Garcia-Sancho A, Baile M, Lopez-Jimenez J, Marquet-Palomanes J, Teruel A, Terol M, Benet C, Frutos L, Navarro J, Una J, Suarez M, Cortes M, Contreras J, Ruiz C, Tamayo P, Mucientes J, Sopena-Novales P, Reguilon-Gallego L, Sanchez-Blanco J, Perez-Ceballos E, Jerez A, Ortuno F. Cancer Medicine. 2023 Mar;12(6):6536-6546. doi: <a href='https:\/\/doi.org\/10.1002\/cam4.5424' target='_blank'>10.1002\/cam4.5424<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/36373169' target='_blank'>36373169<\/a><\/p>\n<p>Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Mansouri L, Thorvaldsdottir B, Sutton LA, Karakatsoulis G, Meggendorfer M, Parker H, Nadeu F, Brieghel C, Laidou S, Moia R, Rossi D, Catherwood M, Kotaskova J, Delgado J, Rodriguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarfo L, Mattsson M, Davis Z, Gogia A, Rani L, Baliakas P, Foroughi-Asl H, Jylha C, Skaftason A, Rapado I, Miras F, Martinez-Lopez J, de la Serna J, Hernandez Rivas JM, Thornton P, Larrayoz MJ, Calasanz MJ, Fesus V, Matrai Z, Bodor C, Smedby KE, Espinet B, Puiggros A, Gupta R, Bullinger L, Bosch F, Tazon-Vega B, Baran-Marszak F, Oscier D, Nguyen-Khac F, Zenz T, Terol MJ, Cuneo A, Hernandez-Sanchez M, Pospisilova S, Mills K, Gaidano G, Niemann CU, Campo E, Strefford JC, Ghia P, Stamatopoulos K, Rosenquist R. Leukemia. 2023 Feb;37(2):504. doi: <a href='https:\/\/doi.org\/10.1038\/s41375-023-01813-3' target='_blank'>10.1038\/s41375-023-01813-3<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/36635392' target='_blank'>36635392<\/a><\/p>\n<p>Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Mansouri L, Thorvaldsdottir B, Sutton LA, Karakatsoulis G, Meggendorfer M, Parker H, Nadeu F, Brieghel C, Laidou S, Moia R, Rossi D, Catherwood M, Kotaskova J, Delgado J, Rodr\u00edguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarfo L, Mattsson M, Davis Z, Gogia A, Rani L, Baliakas P, Foroughi-Asl H, Jylh\u00e4 C, Skaftason A, Rapado I, Miras F, Martinez-Lopez J, de la Serna J, Rivas JMH, Thornton P, Larr\u00e1yoz MJ, Calasanz MJ, F\u00e9s\u00fcs V, M\u00e1trai Z, B\u00f6d\u00f6r C, Smedby KE, Espinet B, Puiggros A, Gupta R, Bullinger L, Bosch F, Taz\u00f3n-Vega B, Baran-Marszak F, Oscier D, N&#8217;Guyen-Khac F, Zenz T, Terol MJ, Cuneo A, Hern\u00e1ndez-S\u00e1nchez M, Pospisilova S, Mills K, Gaidano G, Niemann CU, Campo E, Strefford JC, Ghia P, Stamatopoulos K, Rosenquist R. Leukemia. 2023 Feb;37(2):339-347. doi: <a href='https:\/\/doi.org\/10.1038\/s41375-022-01802-y' target='_blank'>10.1038\/s41375-022-01802-y<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/36566271' target='_blank'>36566271<\/a><\/p>\n<p>IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia. Syrykh C, Pons-Brun B, Russi\u00f1ol N, Playa-Albinyana H, Baumann T, Duran-Ferrer M, Kulis M, Carb\u00f3-Meix A, Mozas P, Alcoceba M, Gonz\u00e1lez M, Navarro-Bail\u00f3n A, Colado E, Payer \u00c1R, Aymerich M, Terol MJ, Lu J, Knisbacher BA, Hahn CK, Ruiz-Gasp\u00e0 S, Enjuanes A, Wu CJ, Getz G, Zenz T, L\u00f3pez-Guillermo A, Mart\u00edn-Subero JI, Colomer D, Delgado J, Campo E, Nadeu F. Blood Advances. 2023 Dec 12;7(23):7384-7391. doi: <a href='https:\/\/doi.org\/10.1182\/bloodadvances.2023010132' target='_blank'>10.1182\/bloodadvances.2023010132<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37505099' target='_blank'>37505099<\/a><\/p>\n<p>Immunobiology of cytomegalovirus infection in patients with haematological malignancies undergoing treatment with small molecule inhibitors. Solano De la Asuncion C, Gimenez E, Hernandez-Boluda JC, Terol MJ, Albert E, Lopez-Jimenez J, Garcia-Gutierrez V, Andreu R, Garcia D, Fox ML, Remigia MJ, Amat P, Solano C, Navarro D. British Journal of Haematology. 2023 Mar;200(6):e58-e61. doi: <a href='https:\/\/doi.org\/10.1111\/bjh.18655' target='_blank'>10.1111\/bjh.18655<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/36652997' target='_blank'>36652997<\/a><\/p>\n<style type=\"text\/css\">.fusion-accordian  #accordion-7536-1 .panel-title a .fa-fusion-box{ color: #ffffff;}.fusion-accordian  #accordion-7536-1 .panel-title a .fa-fusion-box:before{ font-size: 14px; width: 14px;}.fusion-accordian  #accordion-7536-1.fusion-toggle-icon-right .fusion-toggle-heading{ margin-right: 32px;}.fusion-accordian  #accordion-7536-1 .panel-title a{font-size:14px;}.fusion-accordian  #accordion-7536-1 .fa-fusion-box { background-color: #212934;border-color: #212934;}.fusion-accordian  #accordion-7536-1 .panel-title a:hover, #accordion-7536-1 .fusion-toggle-boxed-mode:hover .panel-title a { color: #3bafbf;}.fusion-accordian  #accordion-7536-1 .panel-title .active .fa-fusion-box,.fusion-accordian  #accordion-7536-1 .panel-title a:hover .fa-fusion-box { background-color: #3bafbf!important;border-color: #3bafbf!important;}<\/style><div class=\"accordian fusion-accordian\"><div class=\"panel-group fusion-toggle-icon-right\" id=\"accordion-7536-1\" role=\"tablist\">\n<div class=\"fusion-panel panel-default\" role=\"tabpanel\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\"><a aria-expanded=\"false\" aria-selected=\"false\" aria-controls=\"056466c6faedfa4a3\" role=\"tab\" data-toggle=\"collapse\" data-parent=\"#accordion-7536-1\" data-target=\"#056466c6faedfa4a3\" href=\"#056466c6faedfa4a3\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">More publications from 2023<\/span><\/a><\/h4><\/div><div id=\"056466c6faedfa4a3\" class=\"panel-collapse collapse \"><div class=\"panel-body toggle-content fusion-clearfix\">\nImpact of SCHOLAR-1 criteria on CAR-T cell therapy efficacy in aggressive B lymphoma. A real-world GELTAMO\/GETH study. Oreiro M, Gutierrez A, Iacoboni G, Corral L, Reguera J, Abrisqueta P, Delgado J, Terol M, Hernani R, Martinez N, Ortiz V, Bailen R, Gomez-Centurion I, Caballero A, Sanz J, Dominguez L, Hugo L, Musseti A, Ubieto A, Sancho J, Sureda A, Perez A, Barba P, Kwon M, Garcia-Sancho A. Transplantation And Cellular Therapy. 2023 Aug 31;S2666-6367(23)01508-7. doi: <a href='https:\/\/doi.org\/10.1016\/j.jtct.2023.08.026' target='_blank'>10.1016\/j.jtct.2023.08.026<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37659694' target='_blank'>37659694<\/a><\/p>\n<p>Low-risk HPLLs\/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: results from a prospective Spanish study. Muntanola A, Villalobos M, Gonzalez-Villambrosia S, Rodriguez-Salazar M, Jimenez-Ubieto A, Bastidas-Mora G, Cordoba R, Infante M, Vidal M, Diaz F, Baile M, Bastos-Oreiro M, Panizo C, Sancho J, Navarro B, Garcia T, Escoda L, Abrisqueta P, Terol M, de Campo R, Mozas P, Lopez-Guillermo A, Salar A, Montalban C. British Journal of Haematology. 2023 Aug;202(4):776-784. doi: <a href='https:\/\/doi.org\/10.1111\/bjh.18912' target='_blank'>10.1111\/bjh.18912<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37386877' target='_blank'>37386877<\/a><\/p>\n<p>Obinutuzumab plus bendamustine for relapsed\/refractory chronic lymphocytic leukemia and predictive and prognostic impact of genetic alterations: the phase II GABRIELL study. Bravo J, Tello P, Garcia E, Herranz E, Payer A, Castera M, Champ D, Perez A, Gironella M, Zarzoso M, Fores R, Delgado J, Garcia-Marco J, GABRIELL Study Grp Investigators. Leukemia &#038; Lymphoma. 2023 May;64(5):913-926. doi: <a href='https:\/\/doi.org\/10.1080\/10428194.2023.2216327' target='_blank'>10.1080\/10428194.2023.2216327<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37255002' target='_blank'>37255002<\/a><\/p>\n<p>SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination. Pinana J, Martino R, Vazquez L, Lopez-Corral L, Perez A, Chorao P, Avendano Pita A, Pascual M, Sanchez Salinas A, Sanz Linares G, Olave M, Arroyo I, Tormo M, Villalon L, Conesa Garcia V, Gago B, Terol M, Villalba M, Garcia Gutierrez V, Cabero A, Hernandez Rivas J, Ferrer E, Garcia Cadenas I, Teruel A, Navarro D, Cedillo A, Sureda A, Solano C. Bone Marrow Transplantation. 2023 Feb 28;1-14. doi: <a href='https:\/\/doi.org\/10.1038\/s41409-023-01946-0' target='_blank'>10.1038\/s41409-023-01946-0<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/36854892' target='_blank'>36854892<\/a><\/p>\n<p>Torque Teno Virus plasma DNA load: a novel prognostic biomarker in CAR-T therapy. Benzaqu\u00e9n A, Gim\u00e9nez E, Iacoboni G, Guerreiro M, Hernani R, Albert E, Carpio C, Balaguer A, P\u00e9rez A, S de la Asunci\u00f3n C, S\u00e1nchez-Salinas MA, Chor\u00e3o P, Pi\u00f1ana JL, Beas F, Montoro J, Hern\u00e1ndez-Boluda JC, Facal A, Ferrer B, Villalba M, Amat P, Gom\u00e9z MD, Campos D, Terol MJ, Sanz J, Barba P, Navarro D, Solano C. Bone Marrow Transplantation. 2023 Nov 2. doi: <a href='https:\/\/doi.org\/10.1038\/s41409-023-02114-0' target='_blank'>10.1038\/s41409-023-02114-0<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37919456' target='_blank'>37919456<\/a><\/p>\n<\/div><\/div><\/div>\n<\/div><\/div><\/div>\n<\/div><div class=\"nav fusion-mobile-tab-nav\"><ul class=\"nav-tabs nav-justified\"><li><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-a574f324e5d753180d4\" aria-selected=\"false\" tabindex=\"-1\" id=\"mobile-fusion-tab-2022\" href=\"#tab-a574f324e5d753180d4\"><h4 class=\"fusion-tab-heading\">2022<\/h4><\/a><\/li><\/ul><\/div><div class=\"tab-pane fade fusion-clearfix\" role=\"tabpanel\" tabindex=\"0\" aria-labelledby=\"fusion-tab-2022\" id=\"tab-a574f324e5d753180d4\">\n<div style=\"padding-top:4%;padding-left:4%; padding-right:4%; text-align:justify;\">\nA randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results. Lopez-Guillermo A, Canales M, Dlouhy I, Mercadal S, Briones J, Garcia-Sancho A, Sancho J, Moraleda J, Terol M, Salar A, Palomera L, Gardella S, Jarque I, Ferrer S, Bargay J, Lopez A, Panizo C, Muntanola A, Montalban C, Conde E, Hernandez M, Soler A, Marco J, Deben G, Marin J, Tomas J, PETHEMA GELTAMO GELCAB Spanish. Leukemia &#038; Lymphoma. 2022 Jan;63(1):93-100. doi: <a href='https:\/\/doi.org\/10.1080\/10428194.2021.1971216' target='_blank'>10.1080\/10428194.2021.1971216<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/34459702' target='_blank'>34459702<\/a><\/p>\n<p>Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients. Pinana J, Rodriguez-Belenguer P, Caballero D, Martino R, Lopez-Corral L, Terol M, Vazquez L, Calabuig M, Sanz-Linares G, Marin-Jimenez F, Alonso C, Montoro J, Ferrer E, Facal A, Pascual M, Rodriguez-Fernandez A, Olave M, Cascales-Hernandez A, Gago B, Hernandez-Rivas J, Villalon L, Corona M, Roldan-Perez A, Ribes-Amoros J, Gonzalez-Santillana C, Garcia-Sanz R, Navarro D, Serrano-Lopez A, Cedillo A, Soria-Olivas E, Sureda A, Solano C. Annals of Hematology. 2022 Sep;101(9):2053-2067. doi: <a href='https:\/\/doi.org\/10.1007\/s00277-022-04906-8' target='_blank'>10.1007\/s00277-022-04906-8<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/35780254' target='_blank'>35780254<\/a><\/p>\n<p>Best treatment option for patients with refractory aggressive b-cell lymphoma in the car-t cell era: real-world evidence from GELTAMO\/GETH Spanish Groups. Bastos-Oreiro M, Gutierrez A, Reguera J, Iacoboni G, Lopez-Corral L, Terol M, Ortiz-Maldonado V, Sanz J, Guerra-Dominguez L, Bailen R, Mussetti A, Abrisqueta P, Hernani R, Luzardo H, Sancho J, Delgado-Serrano J, Salar A, Grande C, Bento L, de Villambrosia S, Garcia-Belmonte D, Sureda A, Perez-Martinez A, Barba P, Kwon M, Garcia-Sancho A. Frontiers in Immunology. 2022 Jul 12;13:855730. doi: <a href='https:\/\/doi.org\/10.3389\/fimmu.2022.855730' target='_blank'>10.3389\/fimmu.2022.855730<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/35911769' target='_blank'>35911769<\/a><\/p>\n<p>Genetic and phenotypic characterization of HIV-associated aggressive B-cell non-Hodgkin lymphomas, that do not occur specifically in this population: diagnostic and prognostic implications. Baptista MJ, Tapia G, Munoz-Marmol AM, Muncunill J, Garcia O, Montoto S, Gribben JG, Calaminici M, Martinez A, Veloza L, Martinez-Trillos A, Aldamiz T, Menarguez J, Terol MJ, Ferrandez A, Alcoceba M, Briones J, Gonzalez-Barca E, Climent F, Muntanola A, Moraleda JM, Provencio M, Abrisqueta P, Abella E, Colomo L, Garcia-Ballesteros C, Garcia-Caro M, Sancho JM, Ribera JM, Mate JL, Navarro JT. Histopathology. 2022 Dec;81(6):826-840. doi: <a href='https:\/\/doi.org\/10.1111\/his.14798' target='_blank'>10.1111\/his.14798<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/36109172' target='_blank'>36109172<\/a><\/p>\n<p>Ibrutinib in combination with rituximab for indolent clinical forms of mantle cell lymphoma (IMCL-2015): a multicenter, open-label, single-arm, Phase II Trial. Gin\u00e9 E, de la Cruz F, Jim\u00e9nez Ubieto A, L\u00f3pez Jimenez J, Mart\u00edn Garc\u00eda-Sancho A, Terol MJ, Gonz\u00e1lez Barca E, Casanova M, de la Fuente A, Mar\u00edn-Niebla A, Munta\u00f1ola A, Gonz\u00e1lez-L\u00f3pez TJ, Aymerich M, Setoain X, Cort\u00e9s-Romera M, Rotger A, Rodr\u00edguez S, Medina Herrera A, Garc\u00eda Sanz R, Nadeu F, Be\u00e0 S, Campo E, L\u00f3pez-Guillermo A. Journal of Clinical Oncology. 2022 Apr 10;40(11):1196-1205. doi: <a href='https:\/\/doi.org\/10.1200\/JCO.21.02321' target='_blank'>10.1200\/JCO.21.02321<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/35030036' target='_blank'>35030036<\/a><\/p>\n<style type=\"text\/css\">.fusion-accordian  #accordion-7536-2 .panel-title a .fa-fusion-box{ color: #ffffff;}.fusion-accordian  #accordion-7536-2 .panel-title a .fa-fusion-box:before{ font-size: 14px; width: 14px;}.fusion-accordian  #accordion-7536-2.fusion-toggle-icon-right .fusion-toggle-heading{ margin-right: 32px;}.fusion-accordian  #accordion-7536-2 .panel-title a{font-size:14px;}.fusion-accordian  #accordion-7536-2 .fa-fusion-box { background-color: #212934;border-color: #212934;}.fusion-accordian  #accordion-7536-2 .panel-title a:hover, #accordion-7536-2 .fusion-toggle-boxed-mode:hover .panel-title a { color: #3bafbf;}.fusion-accordian  #accordion-7536-2 .panel-title .active .fa-fusion-box,.fusion-accordian  #accordion-7536-2 .panel-title a:hover .fa-fusion-box { background-color: #3bafbf!important;border-color: #3bafbf!important;}<\/style><div class=\"accordian fusion-accordian\"><div class=\"panel-group fusion-toggle-icon-right\" id=\"accordion-7536-2\" role=\"tablist\">\n<div class=\"fusion-panel panel-default\" role=\"tabpanel\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\"><a aria-expanded=\"false\" aria-selected=\"false\" aria-controls=\"fa25e14c326162cca\" role=\"tab\" data-toggle=\"collapse\" data-parent=\"#accordion-7536-2\" data-target=\"#fa25e14c326162cca\" href=\"#fa25e14c326162cca\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">More publications from 2022<\/span><\/a><\/h4><\/div><div id=\"fa25e14c326162cca\" class=\"panel-collapse collapse \"><div class=\"panel-body toggle-content fusion-clearfix\">\nMulti-body-site colonization screening cultures for predicting multi-drug resistant Gram-negative and Gram-positive bacteremia in hematological patients. Torres I, Huntley D, Tormo M, Calabuig M, Hernandez-Boluda J, Terol M, Carretero C, de Michelena P, Perez A, Pinana J, Colomina J, Solano C, Navarro D. BMC Infectious Diseases. 2022 Feb 21;22(1):172. doi: <a href='https:\/\/doi.org\/10.1186\/s12879-022-07154-3' target='_blank'>10.1186\/s12879-022-07154-3<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/35189833' target='_blank'>35189833<\/a><\/p>\n<p>Real world data of anticoagulant treatment in non-valvular atrial fibrillation across renal function status. Calderon J, Martinez F, Fernandez A, Sauri I, Diaz J, Uso R, Trillo J, Redon J, Forner M. Scientific reports. 2022 Apr 12;12(1):6123. doi: <a href='https:\/\/doi.org\/10.1038\/s41598-022-10164-5' target='_blank'>10.1038\/s41598-022-10164-5<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/35414001' target='_blank'>35414001<\/a><\/p>\n<p>Validation of the Burkitt Lymphoma International Prognostic Index in patients treated with two prospective chemoimmunotherapy trials in Spain. Ribera J, Garcia O, Buendia-Urena B, Terol M, Vicent A, Vall-Llovera F, Bergua J, Garcia-Cadenas I, Esteve J, Ribera J, Acuna-Cruz E, Herrera P, Hernandez-Rivas J, Abrisqueta P, Gonzalez-Campos J, Rodriguez C, Bastos-Oreiro M, Genesca E, Caminos N, de Llano M, Cladera A, Sancho J. Leukemia &#038; Lymphoma. 2022 Aug;63(8):1993-1996. doi: <a href='https:\/\/doi.org\/10.1080\/10428194.2022.2053531' target='_blank'>10.1080\/10428194.2022.2053531<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/35343365' target='_blank'>35343365<\/a><\/p>\n<\/div><\/div><\/div>\n<\/div><\/div><\/div>\n<\/div><div class=\"nav fusion-mobile-tab-nav\"><ul class=\"nav-tabs nav-justified\"><li><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-dad86f19f0d357d57f7\" aria-selected=\"false\" tabindex=\"-1\" id=\"mobile-fusion-tab-2021\" href=\"#tab-dad86f19f0d357d57f7\"><h4 class=\"fusion-tab-heading\">2021<\/h4><\/a><\/li><\/ul><\/div><div class=\"tab-pane fade fusion-clearfix\" role=\"tabpanel\" tabindex=\"0\" aria-labelledby=\"fusion-tab-2021\" id=\"tab-dad86f19f0d357d57f7\">\n<div style=\"padding-top:4%;padding-left:4%; padding-right:4%; text-align:justify;\">\nBuilding a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative. Bosch F, Navarro B, Crespo M, Alcoceba M, Sanchez J, Tazon B, Serrano A, Alvarez M, Serrano L, Alonso-Torres P, Villanueva M, Loriente C, Abrisqueta P, Peiro M, Garcia-Marco J, Gonzalez M, Terol M. Annals of Hematology. 2021 Mar;100(3):825-830. doi: <a href='https:\/\/doi.org\/10.1007\/s00277-020-04331-9' target='_blank'>10.1007\/s00277-020-04331-9<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/33409623' target='_blank'>33409623<\/a><\/p>\n<p>CAR-T therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature review. Hernani R, Sancho A, Amat P, Hernandez-Boluda J, Perez A, Pinana J, Carretero C, Goterris R, Gomez M, Saus A, Ferrer B, Teruel A, Terol M, Solano C. Current Research in Translational Medicine. 2021 Jul 22;69(4):103304. doi: <a href='https:\/\/doi.org\/10.1016\/j.retram.2021.103304' target='_blank'>10.1016\/j.retram.2021.103304<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/34303899' target='_blank'>34303899<\/a><\/p>\n<p>Cytomegalovirus-specific T-cell immunity and DNAemia in patients with chronic lymphocytic leukaemia undergoing treatment with ibrutinib. De la Asuncion C, Terol M, Saus A, Olea B, Gimenez E, Albert E, Lopez-Jimenez J, Andreu R, Garcia D, Fox L, Remigia M, Amat P, Solano C, Navarro D. British Journal of Haematology. 2021 Nov;195(4):637-641. doi: <a href='https:\/\/doi.org\/10.1111\/bjh.17732' target='_blank'>10.1111\/bjh.17732<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/34402042' target='_blank'>34402042<\/a><\/p>\n<p>Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia. Jimenez I, Tazon-Vega B, Abrisqueta P, Nieto JC, Bobillo S, Palacio-Garcia C, Carabia J, Valdes-Mas R, Munuera M, Puigdefabregas L, Parra G, Esteve-Codina A, Franco-Jarava C, Iacoboni G, Terol MJ, Garcia-Marco JA, Crespo M, Bosch F. Biomarker Research. 2021 May 20;9(1):37. doi: <a href='https:\/\/doi.org\/10.1186\/s40364-021-00290-z' target='_blank'>10.1186\/s40364-021-00290-z<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/34016160' target='_blank'>34016160<\/a><\/p>\n<p>Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study). Abrisqueta P, Loscertales J, Terol MJ, Ramirez Payer A, Ortiz M, Perez I, Cuellar-Garcia C, Fernandez de la Mata M, Rodriguez A, Lario A, Delgado J, Godoy A, Arguinano Perez JM, Berruezo MJ, Oliveira A, Hernandez-Rivas JA, Garcia Malo MD, Medina A, Garcia Martin P, Osorio S, Baltasar P, Fernandez-Zarzoso M, Marco F, Vidal Mancenido MJ, Smucler Simonovich A, Lopez Rubio M, Jarque I, Suarez A, Fernandez Alvarez R, Lancharro Anchel A, Rios E, Losada Castillo MC, Perez Persona E, Garcia Munoz R, Ramos R, Yanez L, Bello JL, Loriente C, Acha D, Villanueva M. Clinical Lymphoma, Myeloma &#038; Leukemia. 2021 Dec;21(12):e985-e999. doi: <a href='https:\/\/doi.org\/10.1016\/j.clml.2021.07.022' target='_blank'>10.1016\/j.clml.2021.07.022<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/34511320' target='_blank'>34511320<\/a><\/p>\n<style type=\"text\/css\">.fusion-accordian  #accordion-7536-3 .panel-title a .fa-fusion-box{ color: #ffffff;}.fusion-accordian  #accordion-7536-3 .panel-title a .fa-fusion-box:before{ font-size: 14px; width: 14px;}.fusion-accordian  #accordion-7536-3.fusion-toggle-icon-right .fusion-toggle-heading{ margin-right: 32px;}.fusion-accordian  #accordion-7536-3 .panel-title a{font-size:14px;}.fusion-accordian  #accordion-7536-3 .fa-fusion-box { background-color: #212934;border-color: #212934;}.fusion-accordian  #accordion-7536-3 .panel-title a:hover, #accordion-7536-3 .fusion-toggle-boxed-mode:hover .panel-title a { color: #3bafbf;}.fusion-accordian  #accordion-7536-3 .panel-title .active .fa-fusion-box,.fusion-accordian  #accordion-7536-3 .panel-title a:hover .fa-fusion-box { background-color: #3bafbf!important;border-color: #3bafbf!important;}<\/style><div class=\"accordian fusion-accordian\"><div class=\"panel-group fusion-toggle-icon-right\" id=\"accordion-7536-3\" role=\"tablist\">\n<div class=\"fusion-panel panel-default\" role=\"tabpanel\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\"><a aria-expanded=\"false\" aria-selected=\"false\" aria-controls=\"019c77a0017653bf2\" role=\"tab\" data-toggle=\"collapse\" data-parent=\"#accordion-7536-3\" data-target=\"#019c77a0017653bf2\" href=\"#019c77a0017653bf2\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">More publications from 2021<\/span><\/a><\/h4><\/div><div id=\"019c77a0017653bf2\" class=\"panel-collapse collapse \"><div class=\"panel-body toggle-content fusion-clearfix\">\nRestoration of the immune function as a complementary strategy to treat Chronic Lymphocytic Leukemia effectively. Moreno C, Munoz C, Terol MJ, Hernandez-Rivas JA, Villanueva M. Journal of Experimental &#038; Clinical Cancer Research. 2021 Oct 15;40(1):321. doi: <a href='https:\/\/doi.org\/10.1186\/s13046-021-02115-1' target='_blank'>10.1186\/s13046-021-02115-1<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/34654437' target='_blank'>34654437<\/a><\/p>\n<\/div><\/div><\/div>\n<\/div><\/div><\/div>\n<\/div><\/div><\/div>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-2{width:100% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-2 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 1.92%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-column-2{width:100% !important;}.fusion-builder-column-2 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-2{width:100% !important;}.fusion-builder-column-2 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<\/div>\n<style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-2{ padding-top : 2%;margin-top : 0px;padding-right : 0px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 0px;}<\/style><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-3 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: #9da0d2;background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#e2e2e2;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\">\n<div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion_builder_column_1_1 1_1 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\">\n<div class=\"fusion-text fusion-text-6\" style=\"transform:translate3d(0,0,0);\"><h5 style=\"text-align: left;\">Projects<\/h5>\n<\/div>\n<div class=\"fusion-tabs fusion-tabs-2 classic horizontal-tabs icon-position-left\"><style type=\"text\/css\">.fusion-tabs.fusion-tabs-2 .nav-tabs li a.tab-link{border-top-color:#f9f9fb;background-color:#f9f9fb;}.fusion-tabs.fusion-tabs-2 .nav-tabs{background-color:#ffffff;}.fusion-tabs.fusion-tabs-2 .nav-tabs li.active a.tab-link,.fusion-tabs.fusion-tabs-2 .nav-tabs li.active a.tab-link:hover,.fusion-tabs.fusion-tabs-2 .nav-tabs li.active a.tab-link:focus{border-right-color:#ffffff;}.fusion-tabs.fusion-tabs-2 .nav-tabs li.active a.tab-link,.fusion-tabs.fusion-tabs-2 .nav-tabs li.active a.tab-link:hover,.fusion-tabs.fusion-tabs-2 .nav-tabs li.active a.tab-link:focus{background-color:#ffffff;}.fusion-tabs.fusion-tabs-2 .nav-tabs li a:hover{background-color:#ffffff;border-top-color:#ffffff;}.fusion-tabs.fusion-tabs-2 .tab-pane{background-color:#ffffff;}.fusion-tabs.fusion-tabs-2 .nav,.fusion-tabs.fusion-tabs-2 .nav-tabs,.fusion-tabs.fusion-tabs-2 .tab-content .tab-pane{border-color:#e2e2e2;}<\/style><div class=\"nav\"><ul class=\"nav-tabs nav-justified\" role=\"tablist\"><li class=\"active\"><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-714bbddfd407dcdb436\" aria-selected=\"true\" id=\"fusion-tab-projects\" href=\"#tab-714bbddfd407dcdb436\"><h4 class=\"fusion-tab-heading\">PROJECTS<\/h4><\/a><\/li><\/ul><\/div><div class=\"tab-content\"><div class=\"nav fusion-mobile-tab-nav\"><ul class=\"nav-tabs nav-justified\"><li class=\"active\"><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-714bbddfd407dcdb436\" aria-selected=\"true\" id=\"mobile-fusion-tab-projects\" href=\"#tab-714bbddfd407dcdb436\"><h4 class=\"fusion-tab-heading\">PROJECTS<\/h4><\/a><\/li><\/ul><\/div><div class=\"tab-pane fade fusion-clearfix in active\" role=\"tabpanel\" tabindex=\"0\" aria-labelledby=\"fusion-tab-projects\" id=\"tab-714bbddfd407dcdb436\">\n<div style=\"padding-top:4%;padding-left:4%; padding-right:4%; text-align:left;\">\n<div style=\"margin-bottom:40px;\">\n<span style=\"color:#3D44AC; font-size:16px;\">Reference: <\/span>PMP21\/00015<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Title: <\/span>Medicina de precisi\u00f3n gen\u00f3mica en neoplasias linfoides (PREGENLINF)<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Funding body: <\/span>Instituto de Salud Carlos III &#8211; Cofinanciado FEDER<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Principal Investigator: <\/span>El\u00edas Campo G\u00fcerri<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Duration: <\/span>2022 &#8211; 2025<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Total budget: <\/span>3.063.060\n<\/div>\n<\/div>\n<\/div><\/div><\/div>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-3{width:100% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-3 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 1.92%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-column-3{width:100% !important;order : 0;}.fusion-builder-column-3 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-3{width:100% !important;order : 0;}.fusion-builder-column-3 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<\/div>\n<style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-3{ padding-top : 2%;margin-top : 0px;padding-right : 0px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 0px;}<\/style><\/div><br \/>\n<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-4 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: #e5e5e5;background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#e2e2e2;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\">\n<div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-4 fusion_builder_column_1_1 1_1 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\">\n<div class=\"fusion-text fusion-text-7\" style=\"transform:translate3d(0,0,0);\"><h5>+ Info<\/h5>\n<\/div>\n<div class=\"fusion-tabs fusion-tabs-3 classic horizontal-tabs icon-position-left\"><style type=\"text\/css\">.fusion-tabs.fusion-tabs-3 .nav-tabs li a.tab-link{border-top-color:#f9f9fb;background-color:#f9f9fb;}.fusion-tabs.fusion-tabs-3 .nav-tabs{background-color:#ffffff;}.fusion-tabs.fusion-tabs-3 .nav-tabs li.active a.tab-link,.fusion-tabs.fusion-tabs-3 .nav-tabs li.active a.tab-link:hover,.fusion-tabs.fusion-tabs-3 .nav-tabs li.active a.tab-link:focus{border-right-color:#ffffff;}.fusion-tabs.fusion-tabs-3 .nav-tabs li.active a.tab-link,.fusion-tabs.fusion-tabs-3 .nav-tabs li.active a.tab-link:hover,.fusion-tabs.fusion-tabs-3 .nav-tabs li.active a.tab-link:focus{background-color:#ffffff;}.fusion-tabs.fusion-tabs-3 .nav-tabs li a:hover{background-color:#ffffff;border-top-color:#ffffff;}.fusion-tabs.fusion-tabs-3 .tab-pane{background-color:#ffffff;}.fusion-tabs.fusion-tabs-3 .nav,.fusion-tabs.fusion-tabs-3 .nav-tabs,.fusion-tabs.fusion-tabs-3 .tab-content .tab-pane{border-color:#e2e2e2;}<\/style><div class=\"nav\"><ul class=\"nav-tabs nav-justified\" role=\"tablist\"><li class=\"active\"><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-40ee9e0a1e6a4d10a55\" aria-selected=\"true\" id=\"fusion-tab-thesis\" href=\"#tab-40ee9e0a1e6a4d10a55\"><h4 class=\"fusion-tab-heading\">THESIS<\/h4><\/a><\/li><\/ul><\/div><div class=\"tab-content\"><div class=\"nav fusion-mobile-tab-nav\"><ul class=\"nav-tabs nav-justified\"><li class=\"active\"><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-40ee9e0a1e6a4d10a55\" aria-selected=\"true\" id=\"mobile-fusion-tab-thesis\" href=\"#tab-40ee9e0a1e6a4d10a55\"><h4 class=\"fusion-tab-heading\">THESIS<\/h4><\/a><\/li><\/ul><\/div><div class=\"tab-pane fade fusion-clearfix in active\" role=\"tabpanel\" tabindex=\"0\" aria-labelledby=\"fusion-tab-thesis\" id=\"tab-40ee9e0a1e6a4d10a55\"><span style=\"color:#3D44AC; font-size:16px;\">Title: <\/span>La leucemia linf\u00e1tica cr\u00f3nica: evoluci\u00f3n clonal y su monitorizaci\u00f3n molecular<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Doctoral candidate: <\/span>Serrano Alcal\u00e1, Alicia<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Director(s): <\/span>Navarro Cubells, Blanca; Terol Caster\u00e1 M\u00aa Jos\u00e9; Chaves Mart\u00ednez, Felipe Javier<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Date of the defense: <\/span>30\/05\/2023<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">University: <\/span>University de Valencia<\/p>\n<p><span style=\"color:#3D44AC; font-size:16px;\">Title: <\/span>Development of bioinformatics tools for the characterization of B cell neoplasms<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Doctoral candidate: <\/span>Fuentes Trillo, Azahara Maria<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Director(s): <\/span>Chaves Mart\u00ednez, Felipe Javier; Navarro Cubells, Blanca; Terol Caster\u00e1, Mar\u00eda Jos\u00e9<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Date of the defense: <\/span>10\/03\/2023<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">University: <\/span>Universitat de Val\u00e8ncia<\/p>\n<\/div><\/div><\/div>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-4{width:100% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-4 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 1.92%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-column-4{width:100% !important;order : 0;}.fusion-builder-column-4 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-4{width:100% !important;order : 0;}.fusion-builder-column-4 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<\/div>\n<style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-4{ padding-top : 2%;margin-top : 0px;padding-right : 0px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 0px;}<\/style><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":[],"acf":[],"_links":{"self":[{"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/pages\/7536"}],"collection":[{"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/comments?post=7536"}],"version-history":[{"count":0,"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/pages\/7536\/revisions"}],"wp:attachment":[{"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/media?parent=7536"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}